The proportion of patients aged at least 16 years with P vivax mono-infection who were treated or not treated appropriately with tafenoquine in accordance with their G6PD status was 99·7% (95% CI 99·4–99·8; 4664/4680). The gene discussed is G6PD; the disease is infection.